Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Position End Date (if temporary) Open Date 12/19/2025 Close Date Open until filled Yes Special Instructions Summary Quick Link for Internal Postings https://jobs.gfcmsu.edu/postings/1717 Notices Great Falls
-
deadlines with the expected time frame with minimal delays -Follows attendance and leave policies by reporting to work on time daily and scheduling leave so that it does not interrupt or interfere with
-
, counseling, psychotherapy, and crisis intervention with individuals and groups across a broad spectrum of developmental and psychological concerns that interfere with effective academic and personal
-
takers complete a commercial program, thereby increasing the likelihood of bar passage, and provide assistance in addressing barriers that may interfere with bar preparation. Hold regular office hours
-
and how they fit within the wider context and future of ESA, visit: Candidates interested are encouraged to visit the ESA website: http://www.esa.int Field(s) of activity for the internship Topic
-
, and secondment may be ordered. However, in principle, such orders may not be issued against one's will. https://www.icrr.u-tokyo.ac.jp/prwps/wp-content/uploads/251031_02-2e.pdf [Work content and job
-
the Employment of University of Tokyo Faculty Members.) https://www.icrr.u-tokyo.ac.jp/prwps/wp-content/uploads/251106_01e.pdf [Work content and job description] Engage in experimental, observational
-
departments to manage students in distress and other situations that may interfere with students' ability to function in the University community. The Case Manager provides individual support, advocacy, and
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with